Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT 2019

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Presenter: Philippe Genereux

September 29, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

Leave It to the Endocrinologist!

Presenter: Sonya Burgess

September 27, 2019

Presentation TCT 2019

The Cardiologist Should Play a Major Role in Diabetes Management!

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

Don't Forget Anticoagulant Therapy!

Presenter: Sanjit Jolly

September 27, 2019

Presentation TCT 2019

The Case for Short-Term (1-6 Months) DAPT

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

The Case for Long-Term (1 Year+) DAPT

Presenter: Usman Baber

September 27, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Most Contemporary DES Will Provide Similar Outcomes!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

The Case for PCI in Most!

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Case for CABG in Most!

Presenter: Michael Borger

September 27, 2019

Presentation TCT 2019

The Case for Optimal Medical Therapy First in Most!

Presenter: William Boden

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

Presenter: Marc Bonaca

September 26, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation ISET 2019

Case-Based Tibial Arterial Disease

Presenter: Alex Powell

January 30, 2019

Advertisement

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Leave It to the Endocrinologist!

The Cardiologist Should Play a Major Role in Diabetes Management!

Don't Forget Anticoagulant Therapy!

The Case for Short-Term (1-6 Months) DAPT

The Case for Long-Term (1 Year+) DAPT

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Most Contemporary DES Will Provide Similar Outcomes!

The Case for PCI in Most!

The Case for CABG in Most!

The Case for Optimal Medical Therapy First in Most!

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

The Role of Antiplatelet Agents in Patients With Diabetes and Coronary Disease

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Case-Based Tibial Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content